The Austrian Toxoplasmosis Register, 1992-2008
We aimed to determine the incidence of primary gestational infections with Toxoplasma gondii and congenital toxoplasmosis in Austria, a country with a nationwide prenatal serological screening program since 1974. We analyzed retrospective data from the Austrian Toxoplasmosis Register of pregnant women with Toxoplasma infection and their offspring with births between 1992 and 2008, identified by the prenatal mandatory screening program. Treatment was administered to women from diagnosis of a Toxoplasma infection until delivery. Infected infants were treated up to 1 year of life routinely. Clinical manifestations in infected infants were monitored at least for 1 year and documented in the register. The Austrian Toxoplasmosis Register included 2147 pregnant women with suspected Toxoplasma infection. Annually, 8.5 per 10 000 women acquired Toxoplasma infection during pregnancy, and 1.0 per 10 000 infants had congenital toxoplasmosis (13% mean transmission rate). Our data showed that women treated according to the Austrian scheme had a 6-fold decrease in the maternofetal transmission rate compared to women without treatment. Results from the Austrian Toxoplasmosis Register show the efficiency of the prenatal screening program. Our results are of clinical relevance for infants, healthcare systems, and policy makers to consider preventive Toxoplasma screening as a potential tool to reduce the incidence of congenital toxoplasmosis..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
---|---|
Enthalten in: |
Clinical infectious diseases - 60(2015), 2, Seite e4 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Prusa, Andrea-Romana [VerfasserIn] |
---|
Links: |
---|
doi: |
10.1093/cid/ciu724 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC1956624147 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1956624147 | ||
003 | DE-627 | ||
005 | 20230714141555.0 | ||
007 | tu | ||
008 | 160206s2015 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1093/cid/ciu724 |2 doi | |
028 | 5 | 2 | |a PQ20160617 |
035 | |a (DE-627)OLC1956624147 | ||
035 | |a (DE-599)GBVOLC1956624147 | ||
035 | |a (PRQ)c1691-d77a38a529d779147ee366cf20c65eea8597c047527348ebab2ec406a9a5421b0 | ||
035 | |a (KEY)0124598820150000060000200004austriantoxoplasmosisregister19922008 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q DE-600 |
100 | 1 | |a Prusa, Andrea-Romana |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Austrian Toxoplasmosis Register, 1992-2008 |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a We aimed to determine the incidence of primary gestational infections with Toxoplasma gondii and congenital toxoplasmosis in Austria, a country with a nationwide prenatal serological screening program since 1974. We analyzed retrospective data from the Austrian Toxoplasmosis Register of pregnant women with Toxoplasma infection and their offspring with births between 1992 and 2008, identified by the prenatal mandatory screening program. Treatment was administered to women from diagnosis of a Toxoplasma infection until delivery. Infected infants were treated up to 1 year of life routinely. Clinical manifestations in infected infants were monitored at least for 1 year and documented in the register. The Austrian Toxoplasmosis Register included 2147 pregnant women with suspected Toxoplasma infection. Annually, 8.5 per 10 000 women acquired Toxoplasma infection during pregnancy, and 1.0 per 10 000 infants had congenital toxoplasmosis (13% mean transmission rate). Our data showed that women treated according to the Austrian scheme had a 6-fold decrease in the maternofetal transmission rate compared to women without treatment. Results from the Austrian Toxoplasmosis Register show the efficiency of the prenatal screening program. Our results are of clinical relevance for infants, healthcare systems, and policy makers to consider preventive Toxoplasma screening as a potential tool to reduce the incidence of congenital toxoplasmosis. | ||
540 | |a Nutzungsrecht: © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. | ||
650 | 4 | |a Toxoplasmosis - prevention & control | |
650 | 4 | |a Pregnancy Complications, Infectious - epidemiology | |
650 | 4 | |a Infectious Disease Transmission, Vertical - prevention & control | |
650 | 4 | |a Antiprotozoal Agents - therapeutic use | |
650 | 4 | |a Toxoplasmosis - diagnosis | |
650 | 4 | |a Toxoplasmosis - epidemiology | |
650 | 4 | |a Medical screening | |
650 | 4 | |a Babies | |
650 | 4 | |a Parasitic diseases | |
650 | 4 | |a Infectious diseases | |
650 | 4 | |a Births | |
700 | 1 | |a Kasper, David C |4 oth | |
700 | 1 | |a Pollak, Arnold |4 oth | |
700 | 1 | |a Gleiss, Andreas |4 oth | |
700 | 1 | |a Waldhoer, Thomas |4 oth | |
700 | 1 | |a Hayde, Michael |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases |d Cary, NC : Oxford Univ. Press, 1992 |g 60(2015), 2, Seite e4 |w (DE-627)131041878 |w (DE-600)1099781-7 |w (DE-576)028046099 |x 1058-4838 |7 nnns |
773 | 1 | 8 | |g volume:60 |g year:2015 |g number:2 |g pages:e4 |
856 | 4 | 1 | |u http://dx.doi.org/10.1093/cid/ciu724 |3 Volltext |
856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/25216688 |
856 | 4 | 2 | |u http://search.proquest.com/docview/1644751499 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_168 | ||
912 | |a GBV_ILN_183 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4219 | ||
951 | |a AR | ||
952 | |d 60 |j 2015 |e 2 |h e4 |